IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 1 - 12 of 1443 stories.
August 25, 2016
US FDA issued a warning letter on 12 August 2016 to the active pharmaceutical ingredient (API) manufacturing facilities of Unimark Remedies Ltd., located at Vapi and Bavla, India; and...
August 23, 2016
Piramal to acquire US HPAPI manufacturer Ash Stevens for $42.95 million Piramal Enterprises Ltd. (Mumbai) has agreed to acquire Ash Stevens Inc. (Riverview, Michigan), a pharmaceutical...
August 18, 2016
Siegfried Holding AG (Zofingen, Switzerland), reports net profits of 14.0 million Swiss francs ($14.5 million) for the first half of 2016, a decrease of 30.4% compared with the first half of 2015. First-half sales increased 76.2%, however to 356.6 million francs....
August 16, 2016
Piramal Enterprises Ltd. (Piramal; Mumbai) has agreed to acquire Ash Stevens Inc. (Riverview, Michigan), a pharmaceutical contract development and manufacturing organization (CDMO), for $42.95 million in cash and an earn-out consideration of up to $10 million. Piramal expects to complete the deal by the end of August....
August 16, 2016
Teva’s API unit reports higher sales with improved business in Europe, US The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries Ltd. (Petaḥ...
August 5, 2016
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries Ltd. (Petaḥ Tiqwa, Israel) reports sales rose 13.1% in the second quarter of 2016 compared with...
August 2, 2016
Nippon Shokubai Co. Ltd. (Osaka), a major producer of acrylic acid and superabsorbent polymers, on Tuesday announced that it has acquired a 21.4% stake in the medical research and...
August 2, 2016
Cambrex reports rise in profits, sales increase on higher volumes Cambrex Corp. (East Rutherford, New Jersey), a manufacturer of small molecule innovator and generic active...
July 28, 2016
Cambrex Corp. (East Rutherford, New Jersey), a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), reports a 4.2% rise in net profits for the...
July 25, 2016
Lonza reports 20% core Ebit growth Lonza has reported sales of 2.02 billion Swiss francs ($2.05 billion) in the first half of 2016, an increase of 6% year over year (YOY), the...
July 20, 2016
The US FDA issued a warning letter on 30 June 2016 to the active pharmaceutical ingredient (API) manufacturing facility of SmithKline Beecham Ltd—located at Worthing, United...
July 20, 2016
Lonza has reported sales of 2.02 billion Swiss francs ($2.05 billion) in the first half of 2016, an increase of 6% year over year (YOY), as a result of “better operational and...
Pages:  [1] 2 3 4 5 6 7 8 9 10 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa